The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Association of CD8 T cell infiltration in the tumor microenvironment with survival outcomes in patients with metastatic renal cell carcinoma (mRCC). This is an ASCO Meeting Abstract from the 2024 ASCO ...

Resolutions adopted by the World Health Assembly represent the highest level of political commitment in global health. Endorsed by Ministers of Health from WHO Member States, these resolutions signal ...

Approximately one in seven adults in the United States has kidney disease, where the organs responsible for filtering waste ...